APA (7th ed.) Citation

AN, H., F, R., M, B., J, S., RQ, C., T, W., . . . R, S. (2022). Performance Evaluation of the Fully Automated NeuMoDx RT-PCR Platform for the Quantification of CMV and EBV DNA in EDTA Plasma: Implications for Clinical Management and Establishment of a Conversion Formula. Microbiology spectrum, 10(6), e0215722. https://doi.org/10.1128/spectrum.02157-22

Chicago Style (17th ed.) Citation

AN, Herdina, Ratzinger F, Breuer M, Schellnegger J, Chen RQ, Watkins-Riedel T, Perkmann-Nagele N, and Strassl R. "Performance Evaluation of the Fully Automated NeuMoDx RT-PCR Platform for the Quantification of CMV and EBV DNA in EDTA Plasma: Implications for Clinical Management and Establishment of a Conversion Formula." Microbiology Spectrum 10, no. 6 (2022): e0215722. https://doi.org/10.1128/spectrum.02157-22.

MLA (9th ed.) Citation

AN, Herdina, et al. "Performance Evaluation of the Fully Automated NeuMoDx RT-PCR Platform for the Quantification of CMV and EBV DNA in EDTA Plasma: Implications for Clinical Management and Establishment of a Conversion Formula." Microbiology Spectrum, vol. 10, no. 6, 2022, p. e0215722, https://doi.org/10.1128/spectrum.02157-22.